Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Can PDSG revenue keep the doors open

For the moment, please set aside the recent positive PR about PDSG

From the last quarterly statement

There was no licensing revenue from MMP

There was licensing revenue of $94,055 (from PDSG?)

Our cash and cash equivalents were $9,507,050

Our Gross Profit for 3 months was $1,751

Our quarterly operating expense was $1,586,23 (this included $230,484 in R&D and $1,355,769 in selling, general and administrative)

With the loss of two directors and their board compensation, without MMP license revenue, with continued litigation costs ....how long do we have before we run out of money?

I am not an accountant and not very familiar with financial statements. Just posting what I see and corrections are always welcome.

Share
New Message
Please login to post a reply